Free medication will soon be provided to low-income cancer patients in the UAE.
It comes following a new agreement between the Ministry of Health and Prevention (MoHAP) and pharmaceutical company, AstraZeneca.
The initiative will benefit those battling bladder and lung cancer as well as patients with lymphoma and acute asthma.
Commenting on the agreement, Leon Wang, Executive VP at International AstraZeneca said: "This initiative, which includes new and innovative treatment for some types of cancer and respiratory diseases, would help patients, who are under limited medical insurance."
Dr. Ruqaya Al Bastaki, Director of MoHAP’s Drug Department said that the initiative would help enhance community responsibility values for companies.
UAE launches annual award to honour changemakers
UAE becomes second country to approve Lipfendra to treat high cholesterol
Sharjah Police recovers AED 500,000 in stolen goods in under 3 hours
UAE welcomes Gaza agreement for Hamas disarmament
Sheikh Abdullah meets UK Foreign Secretary in London
H.H. Sheikh Hamdan attends GCC joint military drill in Bahrain
UAE President discusses regional developments with Syrian counterpart
UAE strongly condemns renewed Iranian hostile attack on Kuwait
